$0.6129
-0.00270-0.44%
At close: -
$0.6280
0.022.46%
After Hours: 1:05 PM EDT
Lyell Immunopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lyell Immunopharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.14 | $-0.20 | 30.0 % |
Jun 2024 | 2024-08-07 | $-0.15 | $-0.20 | 25.0 % |
Mar 2024 | 2024-05-06 | $-0.15 | $-0.21 | 28.6 % |
Dec 2023 | 2024-02-28 | $-0.17 | $-0.23 | 26.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2021 | 2021-11-12 | $2.76M | $2.30M | 19.8 % |
Lyell Immunopharma (LYEL) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.14, which beat the estimate of $-0.20.
The Actual Revenue was $34K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.